C-List & Commercial Catalog Masterclass: Executive Interview on Huiminbao with Dr. Wanyan Ruiyun

Fudan expert shares insights on China’s first national negotiation for the commercial drug list—and its potential to reshape Huiminbao, influence drug pricing, accelerate insurance innovation, and transform drug distribution systems nationwide.